Maxalt RPD

Medicinal product

(Invented) name

Maxalt RPD

Active substance (s)

Rizatriptanas

Strength

10 mg

Pharmaceutical form

geriamasis liofilizatas

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

N02CC04, Rizatriptan

Marketing authorisation holder

UAB Ideal Trade Links, Lietuva

Date of authorisation

2025-10-21

Date of renewal

Documents

2967_Maxalt RPD 10mg_ger_liof_PL.docx

2967_Maxalt RPD 10mg_ger_liof_PZ.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Geriamajame liofilizate yra:	1 vnt.
Rizatriptanas	10 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
118961	105067	1105067	lizdinė plokštelė	N2		Receptinis	LT/L/25/2967/001	Netiekiama	-	-	No	-	-	Download
118962	105068	1105068	lizdinė plokštelė	N3		Receptinis	LT/L/25/2967/002	Netiekiama	-	2025-11-30	No	-	-
118963	105069	1105069	lizdinė plokštelė	N6		Receptinis	LT/L/25/2967/003	Netiekiama	-	2025-11-30	No	-	-

Stadijos

Data	Stadija
2025-10-21	Registruotas